ライフサイエンスコーパス: Pluronic

1 ntration of the adhesion-reducing surfactant pluronic.

2 chimeras and transcription activation by the pluronic.

3 Pluronic 10%, plasma, and serum were used as emulsifiers

4 or of gold nanospheres (AuNS) in presence of pluronic acid (PA) modified single-walled carbon nanotub

5 olymers based on PEO and PPO (Poloxamers and Pluronics) and advances in the area of PEGylation as the

6 haracterization of a hypotonic, gel-forming, Pluronic-based delivery system for vaginal drug administ

7 Pluronic-based oil-in-water microemulsions were synthesi

8 embedded into a reversibly thermoresponsive pluronics-based hydrogel matrix.

9 HPbetaCD, improved cholesterol egress, while Pluronic block copolymers capable of micelle formation s

10 peutic efficacy of Doxil(R) by administering Pluronic block copolymers once the liposomal drug accumu

11 We study the influence of Pluronic concentration, gel height and chemoattractant c

12 Variation of aqueous Pluronic concentrations allows for a systematic variatio

13 nsist of a dendritic polyethylene core and a Pluronic copolymer shell.

14 ipid-PEG conjugates were more effective than Pluronic copolymers in generating stable, surface neutra

15 cy with delayed administration indicate that Pluronic copolymers may provide a novel, membrane-target

16 ic action of thermally-induced adsorption of Pluronic copolymers onto the droplet interface and an in

17 amount of FDA-approved amphiphilic triblock Pluronic copolymers which act as gelling agents.

18 e glycol) (PEO-PPO-PEO) triblock copolymers (Pluronic)] could only disperse MWNTs via ultrasonication

19 Encapsulation of the new probes in Pluronic F 108NF micelles, and subsequent incubation in

20 ve drug levels via reversible conjugation to Pluronic F-108 (PF108), these features translated into r

21 ve MD catheter and one surface modified with Pluronic F-127 (10 mm membrane, 100 kDa molecular weight

22 Pluronic F-68 (F-68) or pluronic F-127 (F-127) was administered either topically

23 e characterized in situ gel composed of 14 % Pluronic F-127 and 1.5 % HPMC K4M polymer.

24 n nanospheres composed of triblock copolymer Pluronic F-127 and bis(2-ethylhexyl) sebacate.

25 iminary studies, we detected that the use of pluronic F-127 appeared to be affecting the depolarizati

26 the optically transparent and biocompatible Pluronic F-127 gel that transitions from liquid to gel a

27 (SCN), quickly migrated to soybean roots in Pluronic F-127 gel.

28 od, the actual imbalanced spectral data from Pluronic F-127 hydrogel and Alpha-Cyclodextrin hydrogel

29 Next, we incorporated thiolated Curcumin-Pluronic F-127 micelles (Cur-M) into our boronic ester-b

30 These results indicate that pluronic F-127 significantly alters depolarization-evoke

31 ns, NC crystallized in the medium containing Pluronic F-127 then coated with albumin ("Cim-F-alb") ha

32 ividual and combined effects of glycerol and Pluronic F-127 were of lesser magnitude than those obtai

33 eatured with amphiphilic triblock copolymer (Pluronic F-127) as a model system to extract/preconcentr

34 Small proportions of glycerol, Pluronic F-127, and glucosylceramide enhanced naproxen e

35 In the absence of pluronic F-127, the KCl-evoked [Ca2+]cyt transient chang

36 ng encapsulated with biodegradable copolymer pluronic F-127-folic acid (F-127-FA), RET-BDP molecules

37 Fura-2 AM is often facilitated by the use of pluronic F-127.

38 in neurons Fura-2 loaded in the presence of pluronic F-127.

39 M in the absence or in the presence of 0.02% pluronic F-127.

40 Pluronic F-68 (F-68) or pluronic F-127 (F-127) was admin

41 A Pluronic F-68 + Tween 80 surfactant mixture with the low

42 serum controls by very low concentrations of Pluronic F-68 and F-127 by 30 minutes, with attachment r

43 Here, we demonstrate the efficacy of Pluronic F-68 in rescuing rat hippocampal neurons from a

44 ing human dentin sections as a substrate and Pluronic F-68 or F-127 at a concentration of 1.2 x 10(-8

45 l media (EMEM) with 10% fetal calf serum and Pluronic F-68 or F-127 in concentrations from 1.2 x 10(-

46 ucts and simultaneously remove the detergent Pluronic F-68 without a loss of low-abundance HCPs.

47 Gelatin Peptone N3, N-Acetyl-L-Cysteine and Pluronic F-68) were assayed in order to improve producti

48 Pluronic F-68, a detergent believed to aid in healing of

49 Pluronic F-68, an 80% hydrophilic member of the Pluronic

50 To solve this problem, a surfactant (Pluronic F108) was chemically modified with the metal-ch

51 could be coordinated to Ce6 encapsulated in Pluronic F127 (F127) micelles by simple admixture.

52 The hydrogels examined were pluronic F127 (PF127), Matrigel and PuraMatrix.

53 od employing self-assembly of the surfactant Pluronic F127 (PF127).

54 vulgaris essential oil using the surfactants Pluronic F127 and Tween 80 by mechanical agitation (Emul

55 Concentrated (18-30%) solutions of Pluronic F127 are freely flowing liquids at low temperat

56 ical nucleic acid (SNA) nanostructures using Pluronic F127 as a thermoresponsive template is reported

57 sidual PVA prevented sufficient coating with Pluronic F127 capable of reducing particle mucoadhesion.

58 tative approaches were used to determine the Pluronic F127 concentration below the critical gel conce

59 A concentration of 30% (w/w) Pluronic F127 depressed the freezing point of an electro

60 nanoparticles embedded in a thermosensitive Pluronic F127 hydrogel (1,25 NP) could affect VNH/VS for

61 glycolic acid (PLGA) nanoparticles loaded in Pluronic F127 hydrogel (1,25 NP) to the adventitia of th

62 of amphiphilic (porphyrin)Sn 1 in an aqueous Pluronic F127 media results in the formation of narrowly

63 stimulation) into the hydrophobic regions of Pluronic F127 micelles, followed by chemical cross-linki

64 laponite along with a surfactant stabilizer (Pluronic F127) and the photoacid generator (PAG), diphen

65 Pluronic F127, representative of the copolymer class, co

66 n in the common biocompatible coating agents Pluronic F127, ss-DNA, and BSA is approximately an order

67 al solution temperature (LCST) properties of Pluronic F127, the particles exhibit temperature respons

68 he use of an amphiphilic triblock copolymer, Pluronic F127, to fabricate a self-healing photosyntheti

69 A 3D-printing template, Pluronic F127, was introduced to coassemble with imine p

70 Pluronic F127-based microemulsions extracted bupivacaine

71 emperature responsive properties utilizing a Pluronic F127/dextran aqueous two-phase system (ATPS) as

72 The PLGA polymer, when emulsified in Pluronic F127/dextran ATPS, forms unique microparticle s

73 ycol)-polylactide copolymer (mPEG-PDLLA) and Pluronic (F127).

74 lso studied with and without the addition of Pluronic-F127, using both microfluidic and thin film hyd

75 s reduced slightly following the addition of Pluronic-F127.

76 ost abundant fatty acid in the filtrate from Pluronic F68 (PF68) fermentation of Cutibacterium acnes

77 as the non-coated polyester analogue and the Pluronic F68 alone had no effect.

78 s (FITC, Alexa647 and BODIPy-TR), mixed with pluronic F68 and linear polyethyleneimine (PEI), and emu

79 s tested, in all assays, it was found that a Pluronic F68 coated poly (decanediol-phenylsuccinate-co-

80 ons of this polymer either with or without a Pluronic F68 stabilizing coating was assessed in vitro u

81 e serum albumin, Tween-80, Triton X-100, and Pluronic-F68.

82 ronic F-68, an 80% hydrophilic member of the Pluronic family of polyethylene-polypropylene-polyethyle

83 ventitial delivery of resveratrol either via Pluronic gel (2-week), or polymer sheath (3-month), effe

84 tides into mouse skin wounds by release from Pluronic gel decreases OPN protein levels at the wound a

85 acted as a growth inhibitor in vivo, we used pluronic gel delivery of RpL17 small interfering RNA to

86 iver OPN antisense oligodeoxynucleotides via Pluronic gel to the surface of injured, juxtaposed small

87 ginine methyl ester (L-NAME) in 22% (wt/vol) Pluronic gel, while the contralateral vessel was coated

88 grafts were treated locally with aspirin in pluronic gel-127, the thrombus area was significantly re

89 Feeding Pluronic L-81 (BASF Wyandotte, Wyandotte, MI), a deterge

90 effects of MCTs could be mimicked by adding Pluronic L81 to LCTs, and in vitro assays indicated that

91 plus an inhibitor of chylomicron formation (Pluronic L81).

92 on of large CM was specifically inhibited by Pluronic L81, a detergent known to inhibit CM secretion

93 Dox was encapsulated within stabilized Pluronic micelles and administered weekly i.v. to the ra

94 Encapsulation of Dox using stabilized Pluronic micelles and localized release using low-freque

95 om of well plates, casting a liquid-phase of Pluronic on top that solidifies via a modest temperature

96 tain a series of in-depth profiles from PLLA/Pluronic-P104 (poly(ethylene oxide-co-propylene oxide) t

97 d copolymer systems, with a surface enriched Pluronic-P104 region, followed by a P104 depletion layer

98 anoemulsification process using coconut oil, Pluronic-P107, and Cremophor EL.

99 precursor and the block-copolymer templates Pluronic P123 and F127 does not occur during evaporation

100 es in the presence of the triblock copolymer Pluronic P123.

101 modified the N-terminal amine of leptin with Pluronic P85 (LepNP85) and administered this conjugate i

102 oly(propylene oxide)-b-poly(ethylene oxide), Pluronic P85 (P85) might permit this protein to penetrat

103 The effects of Pluronic P85 and mild hyperthermia in vitro were tested

104 or localized release of Dox from liposome by Pluronic P85 at the tumor site, which was therapeuticall

105 epNPEG5K), and two conjugates of leptin with Pluronic P85 attached randomly to the lysine amino group

106 control tumors (P = .03) after intratumoral Pluronic P85 but was unchanged after systemic Pluronic P

107 images were carried out to determine whether Pluronic P85 could facilitate release of Dox from Doxil(

108 moral (13 tumors) or intravenous (15 tumors) Pluronic P85 followed by ablation or with ablation alone

109 Tumor pretreatment with Pluronic P85 improved the outcome of RF ablation by decr

110 Acute effects of Pluronic P85 on the size of ablation-induced coagulation

111 orubicin (Dox), with a Pgp inhibitor, either Pluronic P85 or Valspodar (Val).

112 e of tumors ablated after local and systemic Pluronic P85 pretreatment changed by -55% +/- 14 (P = .0

113 At 43 degrees C, 7% and 10% Pluronic P85 reduced in vitro cell viability by 22% +/-

114 Addition of Pluronic P85 resulted in release of Dox from the liposom

115 ngle injection of Doxil(R) was achieved when Pluronic P85 was administered 48h after Doxil(R).

116 and distribution of drug were evaluated when Pluronic P85 was injected 1h, 48h, or 96h after the Doxi

117 for 15-60 minutes with 0%, 7%, or 10% wt/wt Pluronic P85, and cell viability was assessed by using a

118 nvestigate the drug release from liposome by Pluronic P85.

119 luronic P85 but was unchanged after systemic Pluronic P85.

120 Liposome modification with PEG copolymers (Pluronics), phospholipid-PEG conjugates and chitosan wer

121 tric assay for quantitative determination of Pluronic (poloxamer) and Tetronic (poloxamine) macromole

122 Here, we show that Pluronic (Poloxamer) block copolymers are amenable to lo

123 Pluronics polymer material is PCR compatible, and 30% Pl

124 Pluronics polymer phase change valves were implemented i

125 polymer material is PCR compatible, and 30% Pluronics polymer valves provide enough holding pressure

126 ersatility, availability, and ease of use of Pluronic polymers offer major advantages over convention

127 differences, the overall trend was that the pluronic polyol and the mode of administration did not r

128 Pluronic polyols are a family of non-ionic surfactants c

129 Pluronic polyols are easily mixed with either DBP or TCP

130 tudy was to determine the in vivo effects of pluronic polyols combined with either an allograft or an

131 Pluronic polyols may be considered as carriers for osseo

132 udy was to determine the in vitro effects of pluronic polyols, a family of widely used surfactants cu

133 Pluronic polyols, a family of widely used surfactants, i

134 Our data demonstrate that the presence of Pluronic(R) F-127 (0.05-0.30%) also helps enhance resolu

135 In this research, a novel material, Pluronic(R) F-127, which has the properties of polymer a

136 osensitive hydrogel comprised of gelatin and Pluronic(R) F127 components already widely used in human

137 esize that the combination of RES and QUE in Pluronic(R) F127 micelles (mRQ) when co-administered wit

138 earing mice showed that PTX-NCs treated with Pluronic(R) F68 (PEG-PPG-PEG block polymer) significantl

139 arriers composed of the tri-block copolymer, Pluronic(R)F127 (PEO(100)-PPO(65)-PEO(100)).

140 xyl) sebacate (DOS) and a triblock copolymer Pluronic((R)) F-127, which also functions as a surfactan

141 rmed from biocompatible polymers gelatin and Pluronic((R)) F127 that are widely used in humans to ena

142 to quantify the in-depth surface segregated Pluronic region.

143 Thermoresponsive smart electrolytes based on Pluronic solution are developed for active control and t

144 attributed to the sol-gel transition of the Pluronic solution upon temperature change.

145 Coinjection with pluronic SP1017 produced further enhancement of gene exp

146 e of synthetic amphiphilic block copolymers, Pluronics (SP1017).

147 than microemulsions synthesized using other Pluronic surfactants (L44, L62, L64, F77, F87, F88, P104

148 A Tris-Acetate-Phosphate-Pluronic (TAPP) medium that undergoes a thermoreversible

149 ature locally, to approximately 5 degrees C, Pluronics valves were liquefied and easily opened.

150 rieux) were Gram stained, diluted 1:1,000 in Pluronic water, inoculated into 96-well antibiotic plate

151 d using the biocompatible triblock copolymer Pluronic, which allowed the comparison in the transport